How Europe could have more Biotech Champions like Argenx
For decades, the narrative of European biotech has been one of “innovation flight”: brilliant science...
Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far....
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11
We’re in Amsterdam with Sander van Deventer, the CEO of VectorY. We will talk about...
